CLAIM.
” no one has actually passed away from the coronavirus”
DETAILS.
Unreliable: Contrary to the post’s claims, individuals have actually passed away from COVID-19 This appears from the excess mortality seen in 2020, in which a greater number of deaths are happening relative to previous years prior to the pandemic. As reported by several published research studies, antibodies specific for SARS-CoV-2 have actually also been discovered and the novel coronavirus has been revealed to trigger COVID-19
KEY ELIMINATE.
Monoclonal antibodies that bind to SARS-CoV-2 have likewise been found and reported in published studies, and pathologists have been using such antibodies, as well as other methods like in situ hybridization which do not need antibodies, to detect SARS-CoV-2 infection in human tissue.
FULL CLAIM: “nobody has passed away from the coronavirus”; “no novel-coronavirus-specific antibodies have been discovered”; “the novel coronavirus has not satisfied Koch’s postulates”; “the inability to determine monoclonal antibodies for the infection recommends there is no basis for the vaccines”; “the WHO is producing [worldwide] chaos is by prohibiting practically all autopsies of people considered to have actually died from COVID-19”
Initially published by OffGuardian, this article makes numerous claims about the COVID-19 pandemic that have actually been republished in other outlets such as GlobalResearch.ca and Australian National Evaluation, both of which have actually been described as conspiracy sites by Media Bias/Fact Examine.
Health Feedback connected to several researchers relating to the accuracy of Alexov’s claims, including members of the ESP leadership, who reacted with a joint clarification on behalf of the Society. You can check out the ESP’s official information in full here
REVIEW
Claim 1:
The article specifies that Alexov declares that “Nobody has passed away from the coronavirus” and that no antibodies specific to SARS-CoV-2 have been determined. It goes on to say that “ Dr. Alexov made his jaw-dropping observations in a video interview summing up the agreement of individuals in a May 8, 2020, European Society of Pathology (ESP) webinar on COVID-19“
The webinar referenced in the short article, entitled “COVID-19: Unprecedented Daily Challenges in Pathology Laboratories throughout Europe” was undoubtedly arranged by the ESP. Although Alexov is a member, he is not noted among the presenters. Therefore, the claim that Alexov made his remarks at a “agreement of participants” during the ESP webinar– with the implication that his remarks were accepted as part of the clinical or medical agreement– is incorrect. The total proceedings were taped and are publicly offered on the ESP’s YouTube channel
Claim 2:
“ no novel-coronavirus-specific antibodies have been discovered“
This is incorrect. Numerous published studies report the discovery of antibodies that bind specifically to SARS-CoV-2, the causative agent of COVID-19, in addition to antibodies versus SARS-CoV-2 in individuals who had actually been previously contaminated[1-4]
Claim 3:
“ The body forms antibodies specific to pathogens it encounters. These particular antibodies are referred to as monoclonal antibodies“
This description of monoclonal antibodies is unreliable and functions as the springboard for other inaccurate claims relating to pathological findings and COVID-19 vaccines that appear later on in the post, as we will see listed below.
When the body immune system comes across a pathogen, part of its reaction is to produce antibodies against the pathogen, a procedure that is carried out by B cells[5] These antibodies can assist other cells of the immune system recognize and destroy the pathogen. In the case of viral infections, antibodies can likewise bind to the infection to prevent the infection from infecting cells.
The term “monoclonal” suggests that the antibodies come from the very same clone of a B cell. Antibodies produced by clones of the exact same B cell are described as monoclonal antibodies.
On the other hand, polyclonal antibodies, which are produced by clones of different B cells, bind to various antigen-binding sites on the same pathogen. Both monoclonal and polyclonal antibodies are produced commercially for use in numerous laboratory methods, such as the enzyme-linked immunoassay (ELISA), which is utilized to find and measure the levels of particular proteins in a sample, along with immunohistochemistry, a strategy utilized to imagine the existence of specific biomarkers in a sample.
Given that our bodies naturally contain several B cell clones, the pool of antibodies created in reaction to a pathogen would be polyclonal by default, not monoclonal. While it is possible to isolate monoclonal antibodies from a person, this would occur outside of the body and require human intervention in the kind of picking and cleansing a sample to get a particular B cell clone.
Claim 4:
“[Monoclonal antibodies] are an essential tool in pathology. This is done via immunohistochemistry […] For That Reason, in the lack of monoclonal antibodies to the novel coronavirus, pathologists can not verify whether SARS-CoV-2 is present in the body, or whether the illness and deaths credited to it indeed were brought on by the virus rather than by something else“
This is demonstrably incorrect. In its declaration, the ESP clarified that “Monoclonal antibodies able to recognize various elements of the unique coronavirus (SARS-CoV-2) are certainly available.
In addition, the ESP webinar that the post refers to consisted of a particular session devoted to methods for finding SARS-CoV-2 in human tissue This session showed that pathologists are using a variety of techniques to determine whether an individual was contaminated with SARS-CoV-2, consisting of molecular methods such as in situ hybridization (ISH) ISH uses nucleic acids (DNA and RNA) attached to a label, such as a radioactive isotope or fluorescent dye, that bind to viral nucleic acids in human tissue, hence signifying the existence of the infection. The webinar also explains the detection of SARS-CoV-2 in human tissue utilizing immunohistochemistry (IHC) as shown in another released research study[10]
In summary, the article’s claim is incorrect. Monoclonal antibodies for discovering SARS-CoV-2 are available and pathologists utilize a range of methods to spot SARS-CoV-2, as demonstrated in published research studies.
Claim 5:
“ the novel coronavirus has not fulfilled Koch’s postulates“
Koch’s postulates are a set of requirements utilized to determine whether a certain microbe is the cause of a disease. They were initially established by Robert Koch, a German physician who won the Nobel Reward for Physiology or Medicine in 1905 for his deal with tuberculosis. The initial postulates are as follows:
- The microbe need to be discovered in abundance in all organisms suffering from the disease, but should not be found in healthy organisms.
- The organism must be separated from a host consisting of the disease and grown in pure culture.
- Samples of the organism drawn from pure culture should trigger the very same illness when inoculated into a healthy, prone animal in the laboratory.
- The organism need to be isolated from the inoculated ani